Corrigendum to “Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies”
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
SAGE Publishing
2024-03-01
|
| Series: | Cephalalgia Reports |
| Online Access: | https://doi.org/10.1177/25158163241233831 |